UNITY color transp BG.jpg
UNITY Biotechnology, Inc. Reports Second Quarter 2018 Financial Results
09 août 2018 16h05 HE | Unity Biotechnology, Inc.
SAN FRANCISCO, Aug. 09, 2018 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) (NASDAQ:UBX), a biotechnology company developing therapeutics to extend healthspan by slowing, halting or...
UNITY color transp BG.jpg
UNITY Biotechnology, Inc. to Announce Second Quarter 2018 Financial Results
31 juil. 2018 16h05 HE | Unity Biotechnology, Inc.
SAN FRANCISCO, Calif., July 31, 2018 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) (NASDAQ:UBX), a biotechnology company developing therapeutics to extend healthspan by slowing, halting or...
UNITY color transp BG.jpg
UNITY Biotechnology, Inc. Announces First Patient Treated in UBX0101 Phase 1 Trial for Osteoarthritis of the Knee
25 juin 2018 08h00 HE | Unity Biotechnology, Inc.
SAN FRANCISCO, June 25, 2018 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) (NASDAQ:UBX), a biotechnology company developing therapeutics to extend healthspan by slowing, halting or...
UNITY color transp BG.jpg
UNITY Biotechnology, Inc. Added to Russell 3000®, 2000® and MicroCap® Indexes
13 juin 2018 16h00 HE | Unity Biotechnology, Inc.
SAN FRANCISCO, June 13, 2018 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) (NASDAQ:UBX), a biotechnology company developing therapeutics to extend healthspan by slowing, halting or...
UNITY color transp BG.jpg
UNITY Biotechnology, Inc. Reports First Quarter 2018 Financial Results
07 juin 2018 17h00 HE | Unity Biotechnology, Inc.
SAN FRANCISCO, June 07, 2018 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) (NASDAQ:UBX), a biotechnology company developing therapeutics to extend healthspan by slowing, halting or...
UNITY color transp BG.jpg
UNITY Biotechnology, Inc. to Participate in the Goldman Sachs 39th Annual Global Healthcare Conference
05 juin 2018 16h05 HE | Unity Biotechnology, Inc.
SAN FRANCISCO, June 05, 2018 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) (NASDAQ:UBX), a biotechnology company developing therapeutics to extend healthspan by slowing, halting or...
UNITY color transp BG.jpg
UNITY Biotechnology, Inc. to Announce First Quarter 2018 Financial Results
29 mai 2018 16h05 HE | Unity Biotechnology, Inc.
SAN FRANCISCO, May 29, 2018 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) (NASDAQ:UBX), a biotechnology company developing therapeutics to extend healthspan by slowing, halting or...